ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,336Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 356

$1.02M Total Retail Price of All Prescriptions

Rank: 16 out of 356

780 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 780 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,983 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
PREDNISONE 977 644 1 10
THEOPHYLLINE ANHYDROUS 919 526 10 2 65
SPIRIVA 683 365 3 33
FUROSEMIDE 393 271 4 3
PROAIR HFA 391 182 5 53
ADVAIR DISKUS 339 161 6 52
SINGULAIR 310 170 7 80
HYDROCODONE-ACETAMINOPHEN 280 145 S3 8 1
AMOX TR-POTASSIUM CLAVULANATE 251 150 9 128
VENTOLIN HFA 235 127 10 81
POTASSIUM CHLORIDE 224 167 11 12
OMEPRAZOLE 202 139 12 7
ALBUTEROL SULFATE 196 83 13 131
MONTELUKAST SODIUM 193 108 14 142
CEFUROXIME 178 111 15 195
SYMBICORT 176 118 16 147
LEVOFLOXACIN 173 110 17 107
ZOLPIDEM TARTRATE 136 111 18 24
LEVOTHYROXINE SODIUM 127 112 19 8
DIGOXIN 124 94 20 42
GABAPENTIN 122 89 21 5
RANITIDINE HCL 109 61 22 41
DILTIAZEM ER 106 86 23 148
MELOXICAM 101 71 24 27
DILTIAZEM 24HR CD 99 53 25 119
SIMVASTATIN 96 78 26 4
METHYLPREDNISOLONE 91 55 27 179
COMBIVENT 89 34 28 156
LOSARTAN POTASSIUM 87 73 29 16
SERTRALINE HCL 85 49 30 49
FLUTICASONE PROPIONATE 84 70 31 36
TRAMADOL HCL 84 42 31 26
AMLODIPINE BESYLATE 83 54 33 2
FORADIL 78 42 34 353
METFORMIN HCL 77 50 35 13
LISINOPRIL 71 46 36 6
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 37 36 155
CITALOPRAM HBR 70 51 38 35
ADVAIR HFA 65 28 39 260
NEXIUM 65 31 39 40
LOSARTAN-HYDROCHLOROTHIAZIDE 65 42 39 105
TRIAMTERENE-HCTZ 64 55 42 85
AMITRIPTYLINE HCL 63 24 R 43 79
AZITHROMYCIN 62 35 44 88
SEREVENT DISKUS 60 40 45 393
VERAPAMIL ER 58 35 46 158
CLONIDINE HCL 58 57 46 17
KLOR-CON M20 55 23 48 109
MEDROXYPROGESTERONE ACETATE 55 17 48 320
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.